JPMorgan Upgrades Annexon Biosciences (ANNX) to Overweight, 'Positive Outlook on ANX005 in GBS & Pipeline Optionality'
Tweet Send to a Friend
(Updated - March 1, 2024 4:15 AM EST)
JPMorgan analyst Anupam Rama upgraded Annexon Biosciences (NASDAQ: ANNX) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Anupam Rama upgraded Annexon Biosciences (NASDAQ: ANNX) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
